Login to Your Account



CoTherix Acquires Schering's U.S. Rights For Ventavis, Raises $55M

By Karen Pihl-Carey


Wednesday, October 15, 2003
The company formerly known as Exhale Therapeutics Inc. has acquired a new name, a new financing and new U.S. rights to a pulmonary hypertension product. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription